Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001641172-25-013435
Filing Date
2025-06-03
Accepted
2025-06-03 16:15:22
Documents
1
Period of Report
2025-05-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1520
  Complete submission text file 0001641172-25-013435.txt   3258
Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 505 MONTGOMERY STREET 10TH FLOOR SAN FRANCISCO CA 94111
Business Address
Kramer Hilary (Reporting) CIK: 0002071192 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40023 | Film No.: 251019671